Immedica announces publication of 2023 Business Review and Annual & Sustainability Report
Stockholm, April 26, 2024 – Immedica is proud to announce the release of our Business Review and Annual & Sustainability Report for the year 2023. This year marks the most successful period in our history since the company's establishment in 2018, highlighting our substantial progress and achievements. In 2023, Immedica strengthened its position as an emerging leader in the rare disease sector across Europe and the MENA region. Through strategic initiatives and a dedicated focus on our core mission, we have taken significant strides toward becoming a frontrunner in this important field.